213 related articles for article (PubMed ID: 28810836)
21. Fluidity of Poly (ε-Caprolactone)-Based Material Induces Epithelial-to-Mesenchymal Transition.
Mano SS; Uto K; Ebara M
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143443
[TBL] [Abstract][Full Text] [Related]
22. Loss of the Metastasis Suppressor NME1, But Not of Its Highly Related Isoform NME2, Induces a Hybrid Epithelial-Mesenchymal State in Cancer Cells.
Huna A; Nawrocki-Raby B; Padilla-Benavides T; Gavard J; Coscoy S; Bernard D; Boissan M
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918324
[TBL] [Abstract][Full Text] [Related]
23. Switch of ELF3 and ATF4 transcriptional axis programs the amino acid insufficiency-linked epithelial-to-mesenchymal transition.
Lin J; Hou L; Zhao X; Zhong J; Lv Y; Jiang X; Ye B; Qiao Y
Mol Ther; 2024 Jun; 32(6):1956-1969. PubMed ID: 38627967
[TBL] [Abstract][Full Text] [Related]
24. Interstitial flow potentiates TGF-β/Smad-signaling activity in lung cancer spheroids in a 3D-microfluidic chip.
Rahman Z; Bordoloi AD; Rouhana H; Tavasso M; van der Zon G; Garbin V; Ten Dijke P; Boukany PE
Lab Chip; 2024 Jan; 24(3):422-433. PubMed ID: 38087979
[TBL] [Abstract][Full Text] [Related]
25. TGF-β, EMT, and resistance to anti-cancer treatment.
Wang X; Eichhorn PJA; Thiery JP
Semin Cancer Biol; 2023 Dec; 97():1-11. PubMed ID: 37944215
[TBL] [Abstract][Full Text] [Related]
26. Requirement of podocalyxin in TGF-beta induced epithelial mesenchymal transition.
Meng X; Ezzati P; Wilkins JA
PLoS One; 2011 Apr; 6(4):e18715. PubMed ID: 21533279
[TBL] [Abstract][Full Text] [Related]
27. Cisplatin-induced activation of TGF-β signaling contributes to drug resistance.
Imatsuji S; Ujie Y; Odake H; Imoto M; Itoh S; Tashiro E
Oncol Res; 2023; 32(1):139-150. PubMed ID: 38188677
[TBL] [Abstract][Full Text] [Related]
28. Alternative splicing in EMT and TGF-β signaling during cancer progression.
Zhang YE; Stuelten CH
Semin Cancer Biol; 2024 Jun; 101():1-11. PubMed ID: 38614376
[TBL] [Abstract][Full Text] [Related]
29. Role of Dlg5/lp-dlg, a membrane-associated guanylate kinase family protein, in epithelial-mesenchymal transition in LLc-PK1 renal epithelial cells.
Sezaki T; Inada K; Sogabe T; Kakuda K; Tomiyama L; Matsuno Y; Ichikawa T; Matsuo M; Ueda K; Kioka N
PLoS One; 2012; 7(4):e35519. PubMed ID: 22539977
[TBL] [Abstract][Full Text] [Related]
30. Human Chorionic Gonadotropin Regulates the Smad Signaling Pathway by Antagonizing TGF-β in Giant Cell Tumor of Bone.
Xu T; Xu S; Ma G; Chang J; Zhang C; Zhou P; Wang C; Xu P; Yang J; Hu Y; Wu Y
Recent Pat Anticancer Drug Discov; 2024; 19(2):188-198. PubMed ID: 38214358
[TBL] [Abstract][Full Text] [Related]
31. Function and mechanism of exogenous AGR2 in colorectal cancer cells.
Zheng C; Mao Y; Ye J; Zhang M; Chen Y
Heliyon; 2024 Apr; 10(7):e28175. PubMed ID: 38560175
[TBL] [Abstract][Full Text] [Related]
32. Genetically Engineered Lung Cancer Cells for Analyzing Epithelial-Mesenchymal Transition.
Kiełbus M; Czapiński J; Kałafut J; Woś J; Stepulak A; Rivero-Müller A
Cells; 2019 Dec; 8(12):. PubMed ID: 31847480
[TBL] [Abstract][Full Text] [Related]
33. Vitamin A Status Modulates Epithelial Mesenchymal Transition in the Lung: The Role of Furin.
Cabezuelo MT; Torres L; Ortiz-Zapater E; López-Rodas G; Marín MP; Timoneda J; Viña JR; Zaragozá R; Barber T
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674868
[TBL] [Abstract][Full Text] [Related]
34. Hydrostatic pressure mediates epithelial-mesenchymal transition of cholangiocytes through RhoA/ROCK and TGF-β/smad pathways.
Khalifa MO; Yan C; Chai Y; Ito K; Zhang SH; Li TS
PLoS One; 2024; 19(4):e0300548. PubMed ID: 38578740
[TBL] [Abstract][Full Text] [Related]
35. Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.
Mimeault M; Batra SK
Mol Aspects Med; 2014 Oct; 39():3-32. PubMed ID: 23994756
[TBL] [Abstract][Full Text] [Related]
36. Proactive and reactive roles of TGF-β in cancer.
Kuburich NA; Sabapathy T; Demestichas BR; Maddela JJ; den Hollander P; Mani SA
Semin Cancer Biol; 2023 Oct; 95():120-139. PubMed ID: 37572731
[TBL] [Abstract][Full Text] [Related]
37. Polyhydroxylated Fullerene C
Sosnowska M; Kutwin M; Koczoń P; Chwalibog A; Sawosz E
J Inflamm Res; 2023; 16():3739-3761. PubMed ID: 37663761
[TBL] [Abstract][Full Text] [Related]
38. Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer.
Zhang J; Ten Dijke P; Wuhrer M; Zhang T
Protein Cell; 2021 Feb; 12(2):89-106. PubMed ID: 32583064
[TBL] [Abstract][Full Text] [Related]
39. Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial-Mesenchymal Transition.
Fang L; Zhang L; Wang M; He Y; Yang J; Huang Z; Tan Y; Fang K; Li J; Sun Z; Li Y; Tang Y; Liang W; Cui H; Zhu Q; Wu Z; Li Y; Hu Y; Chen W
Cancer Res; 2024 Mar; 84(5):659-674. PubMed ID: 38190710
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow mesenchymal/fibroblastic stromal cells induce a distinctive EMT-like phenotype in AML cells.
Nojszewska N; Idilli O; Sarkar D; Ahouiyek Z; Arroyo-Berdugo Y; Sandoval C; Amin-Anjum MS; Bowers S; Greaves D; Saeed L; Khan M; Salti S; Al-Shami S; Topoglu H; Punzalan JK; Farias JG; Calle Y
Eur J Cell Biol; 2023 Sep; 102(3):151334. PubMed ID: 37354622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
